Drug Maker Incyte Pays $12.6M To Resolve False Claims Suit For Drug Co-Pays

(May 6, 2021, 12:35 PM EDT) -- PHILADELPHIA — Drug manufacturer Incyte Corp. has agreed to pay $12.6 million to settle a false claims lawsuit alleging that it paid kickbacks in the form of patient drug co-pays in exchange for health care providers prescribing the company’s chemotherapy drug Jakafi, according to a May 4 press release by the U.S. Justice Department....